State of the art: What we know about infectious agents and myositis

Current Opinion in Rheumatology

Volumn 23, Issue 6, 2011, Pages 585-594

  Gan, Lu ^a   Miller, Frederick W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Idiopathic inflammatory myopathy; Infection; Infectious myopathy; Pathogenesis

Indexed keywords

AUTOIMMUNE DISEASE; BORRELIA BURGDORFERI; CANDIDA ALBICANS; CANDIDA TROPICALIS; CHIKUNGUNYA ALPHAVIRUS; COXSACKIE VIRUS B; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IDIOPATHIC DISEASE; INFECTION; INFLAMMATORY DISEASE; LEISHMANIA INFANTUM; M MODE ECHOCARDIOGRAPHY; MICROBIAL IDENTIFICATION; MYOSITIS; NONHUMAN; POLYMYOSITIS; PRIORITY JOURNAL; RARE DISEASE; REVIEW; STREPTOCOCCUS PYOGENES; TECHNOLOGY; TORQUE TENO VIRUS; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

ANIMALS; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; INFECTION; MYCOSES; MYOSITIS; PARASITIC DISEASES; VIRUS DISEASES;

EID: 82955187313     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834b5457     Document Type: Review

References (91)

1. Cox S, Limaye V, Hill C, et al. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 2010; 13:117-124.
2. Dalakas MC. Review: an update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011; 37:226-242.
3. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011; 305:183-190.
4. O'Hanlon TP, Miller FW. Genetic risk and protective factors for the idiopathic inflammatory myopathies. Curr Rheumatol Rep 2009; 11: 287-294.
5. Love LA, Weinberg CR, McConnaughey DR, et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum 2009; 60:2499-2504.
6. Marie I, Hachulla E, Cherin P, et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 2005; 53:155-165. (Pubitemid 40530154)
7. Miller FW. Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions. In: Koopman W, Moreland L, editors. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lippincott, Williams & Wilkins; 2005. pp. 1593-1620.
8. Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 2008; 21:473-494.
9. Ytterberg SR. Infectious agents associated with myopathies. Curr Opin Rheumatol 1996; 8:507-513. (Pubitemid 27044438)
10. Miller FW, Hess EV, Clauw DJ, et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000; 43:243-249.
11. Gaisford W, Cooke A. Can infections protect against autoimmunity? Curr Opin Rheumatol 2009; 21:391-396.
12. Wolf A, Wilens SL. Dermatomyositis: a report of two cases with complete autopsy. Am J Pathol 1936; 12:235.3-248.3.
13. Rider LG, Wu L, Mamyrova G, et al. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2010; 49:2381-2390.
14. Manlhiot C, Liang L, Tran D, et al. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Rheumatology (Oxford) 2008; 47:526-529.
15. Pachman LM, Lipton R, Ramsey-Goldman R, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005; 53:166-172. (Pubitemid 40530155)
16. Chen DY, Chen YM, Lan JL, et al. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection? J Clin Virol 2010; 49:290-295.
17. Tsutsumi S, Ohga S, Nomura A, et al. CD4-CD8- T-cell polymyositis in a patient with chronic active Epstein-Barr virus infection. Am J Hematol 2002; 71:211-215. (Pubitemid 35253338)
18. Singh R, Cuchacovich R, Gomez R, et al. Simultaneous occurrence of diabetes mellitus and juvenile dermatomyositis: report of two cases. Clin Pediatr (Phila) 2003; 42:459-462. (Pubitemid 36712738)
19. James JA, Kaufman KM, Farris AD, et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100:3019-3026. (Pubitemid 28022839)
20. Nojima T, Hirakata M, Sato S, et al. A case of polymyositis associated with hepatitis B infection. Clin Exp Rheumatol 2000; 18:86-88. (Pubitemid 30102052)
21. Yakushiji Y, Satoh J, Yukitake M, et al. Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier. Neurology 2004; 63:587-588. (Pubitemid 39031404)
22. Kase S, Shiota G, Fujii Y, et al. Inclusion body myositis associated with hepatitis C virus infection. Liver 2001; 21:357-360. (Pubitemid 32910561)
23. Tsuruta Y, Yamada T, Yoshimura T, et al. Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi 2001; 92:370-376.
24. Freitas MR, Neves MA, Nascimento OJ, et al. Inclusion body myositis and HIV infection. Arq Neuropsiquiatr 2008; 66 (2B):428-430. (Pubitemid 352030301)
25. Dalakas MC, Rakocevic G, Shatunov A, et al. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol 2007; 61:466-475. (Pubitemid 46878774)
26. Johnson RW, Williams FM, Kazi S, et al. Human immunodeficiency virusassociated polymyositis: a longitudinal study of outcome. Arthritis Rheum 2003; 49:172-178. (Pubitemid 36418274)
27. Ozden S, Gessain A, Gout O, Mikol J. Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. Clin Infect Dis 2001; 32:510-514. (Pubitemid 32173642)
28. Matsuura E, Umehara F, Nose H, et al. Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol 2008; 67:41-49.
29. Saito M, Higuchi I, Saito A, et al. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 2002; 186:1231-1241. (Pubitemid 35193001)
30. Gilbert DT, Morgan O, Smikle MF, et al. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 2001; 104:101-104. (Pubitemid 32977011)
31. Sherman MP, Amin RM, Rodgers-Johnson PE, et al. Identification of human T cell leukemia/lymphoma virus type I antibodies,;1; DNA, and protein in patients with polymyositis. Arthritis Rheum 1995; 38:690-698.
32. Magro CM, Iwenofu OH, Kerns MJ, et al. Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection. J Cutan Pathol 2009; 36:853-858.
33. Chandrakasan S, Singh S, Ratho RK, et al. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis. Rheumatol Int 2009; 29:565-567.
34. Lewkonia RM, Horne D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995; 21:430-432.
35. Mamyrova G, Rider LG, Haagenson L, et al. Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 2005; 294:2170-2171. (Pubitemid 41571133)
36. Chevrel G, Borsotti JP, Miossec P. Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow-up study. Rheumatology (Oxford) 2003; 42:349-352. (Pubitemid 36305623)
37. Douche-Aourik F, Berlier W, Feasson L, et al. Detection of enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or fibromyalgia and healthy subjects. J Med Virol 2003; 71:540-547. (Pubitemid 37309925)
38. Pachman LM, Litt DL, Rowley AH, et al. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 1995; 38:1513-1518.
39. Leff RL, Love LA, Miller FW, et al. Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 1992; 339:1192-1195.
40. Pachman LM, Hayford JR, Hochberg MC, et al. New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40:1526-1533. (Pubitemid 27430966)
41. Gergely P Jr, Blazsek A, Danko K, et al. Detection of TT virus in patients with idiopathic inflammatory myopathies. Ann N Y Acad Sci 2005; 1050:304-313. (Pubitemid 41129448)
42. Koch MJ, Brody JA, Gillespie MM. Childhood polymyositis: a case-control study. Am J Epidemiol 1976; 104:627-631.
43. Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-Leon Rosales S, et al. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case series. Clin Exp Rheumatol 1999; 17:289-296. (Pubitemid 29265675)
44. Nguyen H, Le C. Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report. J Med Case Reports 2010; 4:187.
45. Namba T, Brunner NG, Grob D. Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polymyositis and myocarditis. J Neurol Sci 1973; 20:231-242.
46. Calore EE, Minkovski R, Khoury Z, et al. Skeletal muscle pathology in 2 siblings infected with Toxoplasma gondii. J Rheumatol 2000; 27:1556-1559. (Pubitemid 30354065)
47. Rebolledo DL, Minniti AN, Grez PM, et al. Inclusion body myositis: a view from the Caenorhabditis elegans muscle. Mol Neurobiol 2008; 38:178-198.
48. Posnett DN. Herpesviruses and autoimmunity. Curr Opin Investig Drugs 2008; 9:505-514. (Pubitemid 351677905)
49. Ramirez-Rivera J, Vega-Cruz AM, Jaume-Anselmi F. Polymyositis: rare complication of hepatitis B vaccination: an unusual cause of toxic shock syndrome. Bol Assoc Med P R 2003; 95:13-16.
50. Altman A, Szyper-Kravitz M, Shoenfeld Y. HBV vaccine and dermatomyositis: is there an association? Rheumatol Int 2008; 28:609-612.
51. Kozireva SV, Zestkova JV, Mikazane HJ, et al. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Rheumatol 2008; 35:1265-1270. (Pubitemid 352000769)
52. Holt P, Kibblewhite K. Acute polymyositis and myoglobinuric renal failure associated with influenza A infection. N Z Med J 1995; 108:463.
53. Harati Y, Niakan E, Bergman EW. Childhood dermatomyositis in monozygotic twins. Neurology 1986; 36:721-723. (Pubitemid 16074250)
54. Winkelmann RK. Influenza vaccine and dermatomyositis. Lancet 1982; 2:495. (Pubitemid 12043948)
55. Jani FM, Gray JP, Lanham J. Influenza vaccine and dermatomyositis. Vaccine 1994; 12:1484.
56. Miller FW, Love LA, Biswas T, et al. Viral and host genetic factors influence encephalomyocarditis virus-induced polymyositis in adult mice. Arthritis Rheum 1987; 30:549-556. (Pubitemid 17108108)
57. Dalakas MC, Gravell M, London WT, et al. Morphological changes of an inflammatory myopathy in rhesus monkeys with simian acquired immunodeficiency syndrome. Proc Soc Exp Biol Med 1987; 185:368-376.
58. Ytterberg SR. Coxsackievirus B 1 induced murine polymyositis: acute infection with active virus is required for myositis. J Rheumatol 1987; 14:12-18. (Pubitemid 17054759)
59. Gomez RM, Solana ME, Levander OA. Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruziinoculated mice. J Parasitol 2002; 88:541-547. (Pubitemid 34686517)
60. Andersson J, Englund P, Sunnemark D, et al. CBA/J mice infected with Trypanosoma cruzi: an experimental model for inflammatory myopathies. Muscle Nerve 2003; 27:442-448. (Pubitemid 36397062)
61. Morrison TE, Whitmore AC, Shabman RS, et al. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006; 80:737-749. (Pubitemid 43062886)
62. Lidbury BA, Rulli NE, Suhrbier A, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 2008; 197:1585-1593. (Pubitemid 351706489)
63. Morrison TE, Oko L, Montgomery SA, et al. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 2011; 178:32-40.
64. Paciello O, Wojcik S, Gradoni L, et al. Syrian hamster infected with Leishmania infantum: a new experimental model for inflammatory myopathies. Muscle Nerve 2010; 41:355-361.
65. Heiner JD, Ball VL. A child with benign acute childhood myositis after influenza. J Emerg Med 2010; 39:316-319.
66. Koliou M, Hadjiloizou S, Ourani S, et al. A case of benign acute childhood myositis associated with influenza A (H1N1) virus infection. Clin Microbiol Infect 2010; 16:193-195.
67. Rubin E, De la Rubia L, Pascual A, et al. Benign acute myositis associated with H1N1 influenza A virus infection. Eur J Pediatr 2010; 169:1159-1161.
68. Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection 2004; 32:199-203. (Pubitemid 39070598)
69. Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 43:953-960. (Pubitemid 44631092)
70. Ramoutar DN, Tang SW, Rodrigues J, Holdsworth BJ. Infective myositis: a rare but important cause of elbow pain in the immunocompromised patient. J Shoulder Elbow Surg 2010; 19:e14-e16.
71. Lehman D, Tseng CW, Eells S, et al. Staphylococcus aureus Panton- Valentine leukocidin targets muscle tissues in a child with myositis and necrotizing fasciitis. Clin Infect Dis 2010; 50:69-72.
72. Pujol Olmo A, Pineiro Aguin Z, Viros Porcuna D, et al. Sudden myositis of the posterior cervical muscular compartment: case report. Acta Otorrinolaringol Esp 2010; 61:81-84.
73. Yassin M, Yadavalli GK, Alvarado N, Bonomo RA. Streptococcus anginosus (Streptococcus milleri Group) pyomyositis in a 50-year-old man with acquired immunodeficiency syndrome: case report and review of literature. Infection 2010; 38:65-68.
74. Nord J, Elemam A, Mandell W. Myositis as an unusual presentation of secondary syphilis. South Med J 2010; 103:807-808.
75. Yacyshyn E, Chiowchanwisawakit P, Emery DJ, et al. Syphilitic myositis: a case-based review. Clin Rheumatol 2011; 30:729-733.
76. Li DM, Xiu DR, Li RY, et al. Aspergillus flavus myositis in a patient after liver transplantation. Clin Transplant 2008; 22:508-511.
77. Zaidan M, Ottaviani S, Polivka M, et al. Aspergillus-related myositis: a case report and review of the literature. Semin Arthritis Rheum 2011 [Epub ahead of print].
78. Javier RM, Sibilia J, Lugger AS, et al. Fatal Aspergillus fumigatus myosiis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 2001; 20:810-813. (Pubitemid 34020459)
79. Schwartz DM, Morgan ER. Multimodality imaging of Candida tropicalis myositis. Pediatr Radiol 2008; 38:473-476.
80. Tsai SH, Peng YJ, Wang NC. Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient. Am J Med Sci 2006; 331:292-294.
81. Basuroy R, Pennisi R, Robertson T, et al. Parasitic myositis in tropical Australia. Med J Aust 2008; 188:254-256.
82. Kubota T, Itoh M. Sparganosis associated with orbital myositis. Jpn J Ophthalmol 2007; 51:311-312.
83. Plonquet A, Bassez G, Authier FJ, et al. Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia. Muscle Nerve 2003; 27:761-765. (Pubitemid 36667488)
84. Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clin Exp Immunol 2010; 160:15-21.
85. O'Hanlon TP, Rider LG, Mamyrova G, et al. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006; 54:3670-3681. (Pubitemid 44737180)
86. Gourley M, Miller FW. Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol 2007; 3:172-180. (Pubitemid 46416266)
87. Belak S, Thoren P, LeBlanc N, Viljoen G. Advances in viral disease diagnostic and molecular epidemiological technologies. Expert Rev Mol Diagn 2009; 9:367-381.
88. Fournier-Wirth C, Jaffrezic-Renault N, Coste J. Detection of blood-transmissible agents: can screening be miniaturized? Transfusion 2010; 50:2032-2045.
89. Vigil A, Davies DH, Felgner PL. Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol 2010; 5:241-251.
90. Sato T, Takayanagi A, Nagao K, et al. Simple PCR-based DNA microarray system to identify human pathogenic fungi in skin. J Clin Microbiol 2010; 48:2357-2364.
91. Curran T, Coulter WA, Fairley DJ, et al. Development of a novel DNA microarray to detect bacterial pathogens in patients with chronic obstructive pulmonary disease (COPD). J Microbiol Methods 2010; 80:257-261.